Effects of Intravenous Lidocaine on Endometriosis Pain
- Status
- COMPLETED
- Phase
- NA
Clinical Trials Related to Pfizer
Related studies linked through entity extraction aliases.
A Study To Evaluate The Safety And Effects On The Body Of An Investigational Drug Using An Endotoxin-Induced Inflammatory Response Model
- Status
- TERMINATED
- Phase
- PHASE1
13vPnC Multidose Vial Safety, Tolerability and Immunogenicity Study in Healthy Infants.
- Status
- COMPLETED
- Phase
- PHASE3
Comparision of Blood Pressure Variability Between Amlodipine and Losartan
- Status
- COMPLETED
- Phase
- PHASE4
The Long-term Antibody Persistence of MenACWY-TT Vaccine (PF-06866681) Versus Meningitec(Registered) or Mencevax(Registered) ACWY in Healthy Adolescents and Adults and a Booster Dose of MenACWY-TT Administered 10 Years Post Primary Vaccination
- Status
- COMPLETED
- Phase
- PHASE3
Evaluation Of Acceptability And Satisfaction Of Hemophilia Patients Treated With FusENGO
- Status
- COMPLETED
- Phase
- N/A
A Study To Observe Safety And Blood Concentrations Of PF-06412562 During And Following The Oral Administration Of Multiple Doses Of PF-06412562 In Healthy Adult Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
A Study of the Efficacy and Safety of Ertugliflozin Monotherapy in the Treatment of Participants With Type 2 Diabetes Mellitus and Inadequate Glycemic Control Despite Diet and Exercise (MK-8835-003, VERTIS MONO)
- Status
- COMPLETED
- Phase
- PHASE3
A Study To Investigate The Drug-Drug Interaction Potential Of Rifampin OnThe Investigational Agent Palbociclib (PD-0332991)
- Status
- COMPLETED
- Phase
- PHASE1
Yoga for Aromatase Inhibitor-associated Joint Pain
- Status
- COMPLETED
- Phase
- NA
A First In Human Study In Healthy People To Evaluate Safety, Toleration, Pharmacokinetics and Pharmacodynamics of Single Oral Doses Of PF-06372865
- Status
- COMPLETED
- Phase
- PHASE1
Effect of Renal Impairment on the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Ertugliflozin in Participants With Type 2 Diabetes Mellitus (MK-8835-009)
- Status
- COMPLETED
- Phase
- PHASE1
A Prospective Non-Interventional Study Protocol With Primary Data Collection - Assessment Of The Long Term Treatment Outcomes Of Genotropin Treatment In Growth Hormone Deficiency (GHD) Patients
- Status
- COMPLETED
- Phase
- N/A
A Study Evaluating Talazoparib (BMN 673), a PARP Inhibitor, in Advanced and/or Metastatic Breast Cancer Patients With BRCA Mutation (EMBRACA Study)
- Status
- COMPLETED
- Phase
- PHASE3
5% Topical Ibuprofen (IBU) for Ankle Sprain
- Status
- COMPLETED
- Phase
- PHASE3
Phase II Safety and Efficacy Study of Crizotinib in East Asian Patients With ROS1 Positive, ALK Negative Advanced NSCLC
- Status
- COMPLETED
- Phase
- PHASE2
VACcination In Methotrexate Treated Rheumatoid Arthritis Patients
- Status
- COMPLETED
- Phase
- PHASE3
Palbociclib (PD-0332991) Combined With Fulvestrant In Hormone Receptor+ HER2-Negative Metastatic Breast Cancer After Endocrine Failure (PALOMA-3)
- Status
- COMPLETED
- Phase
- PHASE3
An Outpatient Study Of The Efficacy, Safety, And Tolerability Of PF-02545920 In The Adjunctive Treatment Of Sub-Optimally Controlled Symptoms of Schizophrenia
- Status
- TERMINATED
- Phase
- PHASE2
Immunogenicity and Safety Study of 1 and 2 Doses of GlaxoSmithKline (GSK) Biologicals' Meningococcal Vaccine MenACWY-TT (GSK134612) in Toddlers, Persistence up to 5 Years After Vaccination and Co-administration With Pfizer's Prevenar 13™Vaccine
- Status
- COMPLETED
- Phase
- PHASE3